Постконтактна профілактика сказу — wound care, risk triage, immunoglobulin, and vaccine series that make rabies PEP nearly 100% effective when started promptly
Rabies virus does not enter the bloodstream — it travels retrograde along peripheral nerves from the inoculation site to the central nervous system, a journey that typically takes weeks to months. That delay is what makes local wound care so powerful: mechanically diluting, detaching, and chemically inactivating virus particles at the bite site, before they attach to nerve endings, is the single highest-yield step in the entire PEP protocol, and it costs almost nothing.
Rabies lyssavirus is an enveloped, single-stranded RNA virus. Its lipid envelope is what makes it so vulnerable to simple detergents:
• Mechanical flushing: running water physically dilutes and dislodges virus-laden saliva deposited in the wound by the bite, scratch, or lick on broken skin/mucosa • Detergent disruption: soap surfactants dissolve the lipid envelope, inactivating virions before they can bind neural cell receptors • Virucidal adjuncts: povidone-iodine or 70% ethanol applied after washing provide additional inactivation, especially useful in field settings without running water • Timing matters but is not binary: washing is most protective immediately after exposure, but WHO recommends thorough washing regardless of how much time has elapsed since the bite, since inoculated virus may still be present locally
Studies in animal models suggest thorough immediate wound washing alone can reduce the risk of developing rabies by a large margin — historically cited figures range widely, but the consistent finding across studies is that washing meaningfully lowers the effective viral inoculum reaching peripheral nerve endings, before RIG and vaccine even begin their work.
Wound washing is not a "soft" recommendation — WHO lists it as an essential, non-negotiable first step for every single category II or III exposure, to be performed even if the patient will also receive RIG and vaccine. No exposure is ever "too minor" to wash.
Correct technique:
• Irrigate thoroughly under running water with soap for a full 15 minutes, gently working suds into puncture wounds rather than just rinsing the surface • Avoid vigorous scrubbing or suturing that can force virus deeper into tissue; if suturing is medically necessary, RIG (if indicated) should be infiltrated first • Apply povidone-iodine, alcohol, or another virucidal agent after washing if available • Update tetanus prophylaxis and assess for bacterial wound infection — bites, especially from carnivores, carry high infection risk independent of rabies
Common errors to avoid: applying folk remedies (chili powder, oils, plant poultices) instead of washing, which delays effective care and can worsen wound infection; assuming a "clean-looking" bite does not need washing; and skipping wound care because vaccine and RIG are already planned — the two are complementary, not substitutes for each other.
Not every animal bite carries the same rabies risk, and PEP is a limited, sometimes scarce resource — so every exposure is triaged. The assessment weighs the biting species' likelihood of carrying rabies, whether the animal is known, healthy, and observable, whether the bite was provoked (defensive) or unprovoked (a red flag for rabid behavior), and the background rabies epidemiology of the region, to classify the exposure and select the appropriate regimen.
Species matters enormously: dogs are responsible for roughly 99% of human rabies deaths worldwide, making any unprovoked or unknown-status dog bite in an endemic region a serious exposure. Bats carry a disproportionate share of risk in regions with controlled canine rabies (e.g. much of the Americas and Europe) — bat bites can be nearly painless and go unnoticed, so any physical contact with a bat, even without an obvious bite mark, is treated as a potential exposure.
Behavioral clues raise or lower suspicion: • Provoked attacks (the animal was startled, defending young, or being handled/fed) are lower risk — normal defensive behavior • Unprovoked attacks — an animal that attacks without cause, appears disoriented, aggressive, or is active during the wrong time of day for its species (e.g. a bat active at midday) — strongly suggest rabies and raise the exposure category • Low-risk species in most regions include small rodents (rats, mice, squirrels) and rabbits, which are very rarely found rabid and typically do not warrant PEP on their own
When the biting domestic dog or cat is available for observation, WHO recommends a 10-day watch: if the animal remains healthy throughout, it was not shedding rabies virus at the time of the bite (rabies virus is only present in saliva shortly before clinical signs appear), and PEP already started can be safely discontinued. If the animal shows signs of illness, dies, or cannot be observed/tested, PEP is completed in full.
A documented, currently valid rabies vaccination in the biting animal lowers risk substantially but does not eliminate it outright in high-incidence settings — clinical judgment and local policy still apply. An animal with unknown vaccination status defaults to treating the exposure as if the animal could be rabid.
Background rabies prevalence in the region and species shifts the threshold for treatment: in a canine-rabies-endemic country, essentially any dog bite of unknown provenance triggers PEP; in a rabies-free or bat-only-reservoir country, a bite from a healthy, observable pet dog with a known owner may not require PEP at all.
WHO exposure categories guide the decision directly: • Category I — touching or feeding animals, licks on intact skin: no PEP needed • Category II — nibbling of uncovered skin, minor scratches without bleeding: wound care + vaccine, RIG generally not required • Category III — single or multiple transdermal bites/scratches, licks on broken skin, contamination of mucous membranes or bites from bats: wound care + RIG + full vaccine series
Vaccination takes about a week to generate a meaningful antibody response — far too slow to intercept virus already at the wound site. Rabies immunoglobulin (RIG) closes that gap: it delivers pre-formed, virus-neutralizing antibody exactly where the virus was inoculated, providing immediate passive protection that covers the patient until their own active immune response, triggered by the vaccine series, takes over.
Active immunization (the vaccine series) requires the immune system to recognize viral antigen, activate B cells, and produce its own neutralizing antibody — a process that takes roughly 7–10 days to reach protective titers, and longer to mature. Rabies virus can begin its nerve-bound journey well within that window in some exposures, especially with bites near richly innervated areas like the face and hands.
RIG is purified antibody — either from hyperimmunized human plasma donors (human rabies immunoglobulin, HRIG) or from hyperimmunized horses (equine rabies immunoglobulin, ERIG, more available and cheaper in many endemic regions) — that neutralizes virus on contact, immediately, without requiring the patient's own immune system to do anything.
RIG is not simply injected intramuscularly like a vaccine — its therapeutic value depends on physically reaching the site where virus was deposited:
• As much of the calculated dose as is anatomically possible is infiltrated directly into and around the wound itself, working the needle through multiple points to bathe the surrounding tissue • Any RIG remaining after full wound infiltration is given intramuscularly at a site distant from the vaccine injection site (never in the same syringe or limb region as the vaccine, to avoid neutralizing the vaccine antigen itself) • For multiple wounds or digits/face where local anatomy limits volume, RIG can be diluted with sterile saline to allow infiltration of all wound sites within the calculated total dose • RIG should be given as soon as possible after the first vaccine dose; if it was not available on day 0, it can still be given up to day 7 of the vaccine series — after that, the patient's own vaccine-induced antibody response is presumed to have begun and additional RIG is no longer recommended
A patient who has already completed a prior full rabies vaccine series (or a WHO-recognized abbreviated pre-exposure series) does not need RIG at all on re-exposure — their immune system already remembers the antigen and mounts a fast anamnestic (booster) response, which is why their regimen is just two vaccine doses with no immunoglobulin.
While RIG buys time, the rabies vaccine series is what produces lasting protection. Modern cell-culture and embryonated-egg-based inactivated vaccines are highly immunogenic: a properly spaced series of intramuscular (or intradermal, where approved) doses reliably drives the immune system to produce robust, durable neutralizing antibody, typically detectable within about a week and peaking over the following weeks.
For a previously unvaccinated person, WHO's standard intramuscular Essen regimen is 4 doses given on days 0, 3, 7, and 14 (an older 5-dose regimen adding a day-28 dose is still used in some settings). Each dose is a full vial given in the deltoid (or anterolateral thigh in young children) — never the gluteal area, where absorption is unreliable.
For someone with a documented complete prior rabies vaccination (pre-exposure or a previous full PEP course), only a short 2-dose booster series is needed — day 0 and day 3 — with no RIG, because their immune system already has memory B cells primed to respond rapidly.
Intradermal (ID) regimens, using a fraction of the intramuscular dose split across multiple sites, are WHO-endorsed, dose-sparing alternatives used widely where vaccine supply is limited, with equivalent immunogenicity when performed correctly.
After the first dose, the innate and adaptive immune system begins processing vaccine antigen: antigen-presenting cells activate helper T cells, which drive B cell proliferation and antibody class-switching. Detectable neutralizing antibody typically appears around day 7–10, rising further with each subsequent dose as memory B cells expand and affinity-mature.
Completing every scheduled dose matters — an interrupted series may leave antibody titers below the protective threshold, or fail to establish durable immune memory. Missing a dose by a day or two is not catastrophic and does not require restarting the series, but the remaining doses should be completed as close to the original schedule as possible under clinical guidance.
Rabies is often described as the deadliest infectious disease in the world by case-fatality rate — once neurological symptoms begin, it is almost always fatal, with only a handful of documented survivors ever recorded. That grim fact makes the other half of the story remarkable: correctly and promptly administered post-exposure prophylaxis is essentially 100% effective at preventing the disease from ever developing. Wound washing, appropriately indicated RIG, and a completed vaccine series, together, reliably intercept the virus before it reaches the central nervous system.
Rabies virus's own biology is what makes PEP so effective: unlike bloodborne infections that spread within hours, rabies virus must first replicate locally in muscle tissue near the bite, then attach to and travel retrograde along peripheral nerve axons toward the spinal cord and brain — a slow, mechanically constrained journey that, depending on the wound's distance from the CNS and the viral inoculum, typically takes anywhere from about a week to several months, occasionally longer.
That incubation period is exactly the window PEP exploits: wound washing reduces the starting viral load, RIG neutralizes virus still present locally, and the vaccine series builds the patient's own durable antibody response — all before the virus completes its journey to the nervous system, at which point it becomes essentially untreatable.
Because the incubation period is typically long, PEP should still be started even if a patient presents days, weeks, or in rare cases months after a bite — later-than-ideal PEP is still overwhelmingly likely to prevent disease, and it should never be withheld solely because time has passed since the exposure. "Start immediately" always beats "it's probably too late."
Documented PEP failures are exceptionally rare relative to the millions of people who receive rabies PEP each year, and when they do occur they are almost always traceable to a specific, identifiable breakdown in protocol rather than a failure of the biology itself:
• Wound washing skipped or inadequate, especially for deep puncture wounds • Severe bites to the face, head, or neck — very short nerve distance to the brain — combined with delayed presentation • RIG omitted or under-dosed for a category III exposure in someone without prior vaccination • RIG not infiltrated into the wound itself, only given intramuscularly at a distant site • Vaccine series interrupted, using expired or improperly stored (cold-chain-broken) vaccine, or counterfeit product in some under-regulated markets • Immunocompromised patients, who may mount a weaker antibody response and sometimes warrant closer serologic follow-up
Each of these is a solvable systems and training problem, not an inherent limitation of the biology — which is precisely why global rabies elimination efforts focus heavily on ensuring reliable PEP access and correct administration, alongside canine vaccination campaigns.